» Articles » PMID: 38630006

Sialic Acid-based Probiotic Intervention in Lactating Mothers Improves the Neonatal Gut Microbiota and Immune Responses by Regulating Sialylated Milk Oligosaccharide Synthesis Via the Gut-breast Axis

Overview
Journal Gut Microbes
Date 2024 Apr 17
PMID 38630006
Authors
Affiliations
Soon will be listed here.
Abstract

Human milk oligosaccharides (HMOs) are vital milk carbohydrates that help promote the microbiota-dependent growth and immunity of infants. Sialic acid (SA) is a crucial component of sialylated milk oligosaccharides (S-MOs); however, the effects of SA supplementation in lactating mothers on S-MO biosynthesis and their breastfed infants are unknown. Probiotic intervention during pregnancy or lactation demonstrates promise for modulating the milk glycobiome. Here, we evaluated whether SA and a probiotic (Pro) mixture could increase S-MO synthesis in lactating mothers and promote the microbiota development of their breastfed neonates. The results showed that SA+Pro intervention modulated the gut microbiota and 6'-SL contents in milk of maternal rats more than the SA intervention, which promoted colonization in neonates and immune development. Deficient 6'-SL in the maternal rat milk of knockouts (St6gal1) disturbed intestinal microbial structures in their offspring, thereby impeding immune tolerance development. SA+Pro intervention in lactating St6gal1 rats compromised the allergic responses of neonates by promoting 6'-SL synthesis and the neonatal gut microbiota. Our findings from human mammary epithelial cells (MCF-10A) indicated that the GPR41-PI3K-Akt-PPAR pathway helped regulate 6'-SL synthesis in mammary glands after SA+Pro intervention through the gut - breast axis. We further validated our findings using a human-cohort study, confirming that providing SA+Pro to lactating Chinese mothers increased S-MO contents in their breast milk and promoted gut spp. and spp. colonization in infants, which may help enhance immune responses. Collectively, our findings may help alter the routine supplementation practices of lactating mothers to modulate milk HMOs and promote the development of early-life gut microbiota and immunity.

Citing Articles

The neonatal gut microbiome in health and disease.

Preidis G Gut Microbes. 2025; 17(1):2457499.

PMID: 39868670 PMC: 11776465. DOI: 10.1080/19490976.2025.2457499.

References
1.
Jeanneau C, Chazalet V, Auge C, Soumpasis D, Harduin-Lepers A, Delannoy P . Structure-function analysis of the human sialyltransferase ST3Gal I: role of n-glycosylation and a novel conserved sialylmotif. J Biol Chem. 2004; 279(14):13461-8. DOI: 10.1074/jbc.M311764200. View

2.
Thongaram T, Hoeflinger J, Chow J, Miller M . Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. J Dairy Sci. 2017; 100(10):7825-7833. DOI: 10.3168/jds.2017-12753. View

3.
Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S . Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost. 2004; 92(6):1402-10. DOI: 10.1160/TH04-01-0055. View

4.
Jiao N, Baker S, Nugent C, Tsompana M, Cai L, Wang Y . Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. Physiol Genomics. 2018; 50(4):244-254. DOI: 10.1152/physiolgenomics.00114.2017. View

5.
Seppo A, Kukkonen A, Kuitunen M, Savilahti E, Yonemitsu C, Bode L . Association of Maternal Probiotic Supplementation With Human Milk Oligosaccharide Composition. JAMA Pediatr. 2019; 173(3):286-288. PMC: 6439880. DOI: 10.1001/jamapediatrics.2018.4835. View